Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B Cirrhosis
NCT01987791 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2013-11-19
Summary
To compare the safety and efficacy of 12 months of low dose prednisone with low dose cyclosporine combined with entecavir in patients with thrombocytopenia associated with HBV-related cirrhosis.
Conditions
- Thrombocytopenia
- Hepatitis B
- Cirrhosis
Sponsors & Collaborators
-
Peking University People's Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Primary Completion
- 2013-11-30
More Related Trials
-
Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone
NCT02281929 ·Status: COMPLETED ·Phase: PHASE3
-
Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis
NCT02250391 ·Status: COMPLETED ·Phase: PHASE3
-
Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
NCT04597164 ·Status: RECRUITING
-
Growth Hormone in Decompensated Liver Cirrhosis
NCT05253287 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir
NCT02945956 ·Status: UNKNOWN ·Phase: PHASE4
-
ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study
NCT01798329 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1
NCT00089570 ·Status: COMPLETED ·Phase: PHASE3
-
Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
NCT05304455 ·Status: COMPLETED ·Phase: NA
-
Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication
NCT05128305 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Continuous Renal Replacement Therapy on Systemic Hemodynamics and Lactate Clearance in Critically Ill Cirrhotics With Septic Shock.
NCT04949178 ·Status: UNKNOWN
-
TIPS for PH Patients: an Observational, Cohort Study
NCT06221982 ·Status: RECRUITING
-
Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein
NCT00993941 ·Status: UNKNOWN ·Phase: PHASE2
-
Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis
NCT02526303 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .
NCT03084185 ·Status: UNKNOWN
-
Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition
NCT05011370 ·Status: COMPLETED
-
Cytokine Adsorption in Acute-on-chronic Liver Failure
NCT05019352 ·Status: UNKNOWN ·Phase: NA
-
Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy
NCT02505152 ·Status: UNKNOWN ·Phase: NA
-
Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis
NCT01214226 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035 ·Status: RECRUITING
-
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
NCT07058155 ·Status: RECRUITING ·Phase: PHASE4
-
Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis
NCT05181332 ·Status: UNKNOWN
-
Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic Patients
NCT02427906 ·Status: UNKNOWN
-
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
NCT06562803 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis
NCT04806581 ·Status: UNKNOWN ·Phase: PHASE1
-
Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and Entecavir
NCT02945982 ·Status: UNKNOWN ·Phase: PHASE4